Company Filing History:
Years Active: 2005-2010
Title: Ted Baughman: Innovator in Protein Tyrosine Phosphatase Inhibitors
Introduction
Ted Baughman is a notable inventor based in Bothell, WA (US). He has made significant contributions to the field of biochemistry, particularly in the development of protein tyrosine phosphatase inhibitors. With a total of three patents to his name, Baughman's work has the potential to impact various medical conditions.
Latest Patents
Baughman's latest patents focus on compounds that modulate the biological activity of the protein tyrosine phosphatase-1b (PTP1B) enzyme. These compounds are designed to treat a range of diseases and conditions, including Type 1 and Type 2 diabetes, insulin resistance, obesity, and several types of cancer. The inventions provide innovative methods for addressing health issues where the PTP1B enzyme plays a critical role.
Career Highlights
Throughout his career, Ted Baughman has worked with several companies, including Ceptyr, Inc. and Celltech R&D Limited. His experience in these organizations has contributed to his expertise in the field of biochemistry and patent development.
Collaborations
Baughman has collaborated with notable professionals in his field, including Mark Arnold, Thomas Blaskovich, and Thomas Little. These collaborations have likely enriched his research and innovation efforts.
Conclusion
Ted Baughman is a distinguished inventor whose work in protein tyrosine phosphatase inhibitors holds promise for treating various medical conditions. His contributions to the field of biochemistry continue to pave the way for future innovations.
Inventor’s Patent Attorneys refers to legal professionals with specialized expertise in representing inventors throughout the patent process. These attorneys assist inventors in navigating the complexities of patent law, including filing patent applications, conducting patent searches, and protecting intellectual property rights. They play a crucial role in helping inventors secure patents for their innovative creations.